Mar 1 |
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
|
Feb 29 |
5 Small Drug Stocks to Buy From a Rebounding Industry
|
Feb 26 |
Strength Seen in Lyra Therapeutics, Inc. (LYRA): Can Its 6.9% Jump Turn into More Strength?
|
Feb 21 |
Here's What Could Help Lyra Therapeutics, Inc. (LYRA) Maintain Its Recent Price Strength
|
Jan 17 |
What Makes Lyra Therapeutics, Inc. (LYRA) a Good Fit for 'Trend Investing'
|
Jan 2 |
Lyra Therapeutics: A Risk Assessment
|
Dec 12 |
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Alpine Immune Sciences, Lyra Therapeutics, Harpoon Therapeutics and Journey Medical
|
Nov 15 |
Lyra Therapeutics Insider Ups Holding By 11% During Year
|
Nov 15 |
Executive Chairman of Lyra Therapeutics Harlan Waksal Buys 11% More Shares
|
Nov 7 |
Lyra Therapeutics GAAP EPS of -$0.27, revenue of $544M
|